Optimizing R/R CLL Treatment: Therapy Sequencing and Supportive Care Strategies - Episode 12
Emerging role of doublet triplet therapies in R/R CLL: Expert Perspectives
Panelists discuss how they balance the potential benefits of aggressive first-line treatment in chronic lymphocytic leukemia against the importance of preserving effective options for subsequent lines of therapy, considering factors such as patient prognosis, treatment goals, and the evolving landscape of available therapies.
Video content above is prompted by the following:
- How do you weigh the potential benefit of a more aggressive 1L treatment against limiting available treatment options in later lines of therapy?
Related Content:
